Kyverna Therapeutics Congratulates the Teams at the Universities of Bochum and Magdeburg for a Late Breaker Case Report in a Patient with Refractory Myasthenia Gravis Treated with Investigational KYV-101
The severely disabled and treatment-refractory patient was discharged without symptoms three weeks after KYV-101 infusion and was fully mobile 60 days after, with no observed adverse events related to CAR T-cell therapy The late breaker abstract was presented on November 11, 2023 at the 96th Congres
Kyverna Therapeutics Congratulates Scientific Advisory Board Member Peter A. Merkel, M.D., M.P.H. on Receiving the 2023 ACR Distinguished Clinical Investigator Award
Dr. Merkel will receive the award during the 2023 ACR Convergence Meeting in San Diego, CA for his outstanding contributions to the field of rheumatology EMERYVILLE, Calif., Nov. 11, 2023 /PRNewswire/ — Kyverna Therapeutics, Inc. (Kyverna), a patient-centered clinical-stage biopharmaceutical c
Fapon Inaugurates State-of-the-Art R&D Center in Lexington, MA
LEXINGTON, Mass., Nov. 11, 2023 /PRNewswire/ — Fapon, a global leading life sciences organization, is thrilled to announce the grand opening of its US-based Research and Development (R&D) Center, strategically located in Lexington, Massachusetts. This Center represents Fapon’s unwave
Post Hoc Analysis Showed CIMZIA® (Certolizumab Pegol) Resulted in Meaningful Efficacy for RA Patients with High Levels of Rheumatoid Factor (RF)
A post hoc analysis from the EXXELERATE Phase 4 trial showed that 65.7 percent of CIMZIA-treated patients with rheumatoid arthritis (RA) and high rheumatoid factor (RF) levels achieved low disease activity at Week 1041CIMZIA maintained drug concentrations and achieved Low Disease Activity regardless
/R E M I N D E R — Media Advisory – Prime Minister’s itinerary for Saturday, November 11, 2023/
OTTAWA, ON, Nov. 10, 2023 /CNW/ – Note: All times local National Capital Region, Canada Private meetings 10:45 a.m. The Prime Minister will participate in the National Remembrance Day Ceremony. The Minister of Veterans Affairs and Associate Minister of National Defence, Ginette Petitpas
Panduit Australia Launches Panduit™ Uninterruptible Power Supply
Panduit delivers highly efficient and reliable power protection for IT equipment MELBOURNE, Australia, Nov. 10, 2023 /PRNewswire/ — Panduit Australia releases Panduit™ Uninterruptible Power Supply (UPS), delivering highly efficient and reliable power that provides protection and backup power
Mobile Broadband That Truly Connects
— China Unicom & Huawei’s Excursion into the Steppes of Inner Mongolia SHENZHEN, China, Nov. 11, 2023 /PRNewswire/ — In Inner Mongolia, one of China’s five autonomous regions, the prefecture-level city of Chifeng is renowned for its grassy plains that stretch on for miles and
Resecurity Joins Palo Alto Networks Cortex XSOAR Marketplace
Resecurity® Integrates with Palo Alto Networks Cortex XSOAR Marketplace, Offering Enhanced Security Solutions LOS ANGELES, Nov. 11, 2023 /PRNewswire/ — Resecurity® (USA), a leading provider of advanced cybersecurity solutions, is pleased to announce its integration with the Palo Alto Network
UNIVERSAL MUSIC GROUP’S FAMILY OF ARTISTS AND LABELS NOMINATED ACROSS ALL GENRES FOR THE 66TH ANNUAL GRAMMY AWARDS
boygenius, Jon Batiste, Billie Eilish, Lana Del Rey, Olivia Rodrigo and Taylor Swift receive nominations that include Record of the Year, Album of the Year, Song of the Year and many more. Gracie Abrams, Ice Spice, Coco Jones, Noah Kahan and The War and Treaty nominated in the Best New Artist Categ
CGTN：People-centered approach: China to continue enhancement of disaster prevention efforts
BEIJING, Nov. 11, 2023 /PRNewswire/ — China says it will continue to uphold a people-centered approach and accelerate progress in improving disaster prevention, mitigation, and relief capabilities, as Beijing, Hebei Province and several other parts of the country were hit by floods and geologi
